EPAS1 and paraganglioma: This served as genetic confirmation of isolated EPAS1-gain-of-function syndrome and allowed the evaluation of HIF-2α in the absence of common somatic mutations causing alterations in the hypoxia pathway resulting in paraganglioma/pheochromocytoma.